Terms: = Pancreatic cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
13 results:
1. cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/pdgfr-β Mediated Paracrine Signaling Network.
Yan J; Xiao G; Yang C; Liu Q; Lv C; Yu X; Zhou Z; Lin S; Bai Z; Lin H; Zhang R; Liu C
Aging Dis; 2024 Feb; 15(1):369-389. PubMed ID: 37307823
[TBL] [Abstract] [Full Text] [Related]
2. Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.
Shi YH; Xu QC; Zhu YQ; Liu ZD; Zhao GY; Liu Q; Wang XY; Wang JQ; Xu X; Su Q; Lai JM; Huang CS; Yin XY
Mol Ther; 2023 Feb; 31(2):503-516. PubMed ID: 36384875
[TBL] [Abstract] [Full Text] [Related]
3. pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460.
Zhu XX; Li JH; Ni X; Wu X; Hou X; Li YX; Li SJ; Zhao W; Yin XY
Cancer Sci; 2022 Nov; 113(11):3735-3750. PubMed ID: 36047966
[TBL] [Abstract] [Full Text] [Related]
4. pdgfr-β
Hu G; Huang L; Zhong K; Meng L; Xu F; Wang S; Zhang T
Aging (Albany NY); 2021 May; 13(10):13693-13707. PubMed ID: 33946048
[TBL] [Abstract] [Full Text] [Related]
5. Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.
Ueno M; Ikeda M; Sasaki T; Nagashima F; Mizuno N; Shimizu S; Ikezawa H; Hayata N; Nakajima R; Morizane C
BMC Cancer; 2020 Nov; 20(1):1105. PubMed ID: 33198671
[TBL] [Abstract] [Full Text] [Related]
6. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.
Noguchi R; Yoshimatsu Y; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):667-674. PubMed ID: 33146842
[TBL] [Abstract] [Full Text] [Related]
7. Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric cancer.
Meng C; Xia S; He Y; Tang X; Zhang G; Zhou T
Comput Math Methods Med; 2020; 2020():5479279. PubMed ID: 32908579
[TBL] [Abstract] [Full Text] [Related]
8. Design, synthesis, biological evaluation and molecular modeling study of new thieno[2,3-d]pyrimidines with anti-proliferative activity on pancreatic cancer cell lines.
Salem MSH; Abdel Aziz YM; Elgawish MS; Said MM; Abouzid KAM
Bioorg Chem; 2020 Jan; 94():103472. PubMed ID: 31813475
[TBL] [Abstract] [Full Text] [Related]
9. Targeting Purinergic Receptor P2Y2 Prevents the Growth of pancreatic Ductal Adenocarcinoma by Inhibiting cancer Cell Glycolysis.
Hu LP; Zhang XX; Jiang SH; Tao LY; Li Q; Zhu LL; Yang MW; Huo YM; Jiang YS; Tian GA; Cao XY; Zhang YL; Yang Q; Yang XM; Wang YH; Li J; Xiao GG; Sun YW; Zhang ZG
Clin Cancer Res; 2019 Feb; 25(4):1318-1330. PubMed ID: 30420446
[TBL] [Abstract] [Full Text] [Related]
10. Melatonin Synergizes with Sorafenib to Suppress pancreatic cancer via Melatonin Receptor and pdgfr-β/STAT3 Pathway.
Fang Z; Jung KH; Yan HH; Kim SJ; Rumman M; Park JH; Han B; Lee JE; Kang YW; Lim JH; Hong SS
Cell Physiol Biochem; 2018; 47(5):1751-1768. PubMed ID: 29953970
[TBL] [Abstract] [Full Text] [Related]
11. Cotargeting of MEK and pdgfr/STAT3 Pathways to Treat pancreatic Ductal Adenocarcinoma.
Sahu N; Chan E; Chu F; Pham T; Koeppen H; Forrest W; Merchant M; Settleman J
Mol Cancer Ther; 2017 Sep; 16(9):1729-1738. PubMed ID: 28619758
[TBL] [Abstract] [Full Text] [Related]
12. Impact of p53 and pdgfr-β Expression on Metastasis and prognosis of Patients with pancreatic cancer.
Kurahara H; Maemura K; Mataki Y; Sakoda M; Shinchi H; Natsugoe S
World J Surg; 2016 Aug; 40(8):1977-84. PubMed ID: 26940582
[TBL] [Abstract] [Full Text] [Related]
13. Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas.
Fazio N; Cinieri S; Lorizzo K; Squadroni M; Orlando L; Spada F; Maiello E; Bodei L; Paganelli G; Delle Fave G; de Braud F
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S87-94. PubMed ID: 21129617
[TBL] [Abstract] [Full Text] [Related]